This statistic shows the research and development spending of dedicated biotechnology companies in selected countries for 2014 (or latest year available), by application. In that year, biotechnology companies in Italy spent 89.6 percent of their research and development expenditures on health applications.

Biotech R&D expenditure

Many countries spend a significant portion of their biotechnology R&D expenditures on the health industry, while the agricultural sector often garners the next largest portion of expenditures. In Germany, the health sector contributed to 82.3 percent of biotechnology R&D expenditures and 1.4 percent of spending was under the agricultural sector in 2015. As of 2012, the United States was the largest biotechnology region in the world, generating 65.5 billion U.S. dollars in revenue from the industry.

Biotechnology uses the processes of living organisms to develop or modify products for a large variety of applications. In the health sector, biotechnology has enabled pharmacogenomics, which allows for the analysis of responses to medications based on an individual’s genetics. Using biotechnology to produce pharmaceutical products is also common worldwide. Sanofi’s biotech treatment for hypercholesterolemia, Alirocumab, was released in 2015 and is expected to generate 2.18 billion U.S. dollars in global sales by 2020.

Currently, the biotech drug Humira, is one of the world’s best-selling drugs. In 2015, AbbVie generated 14 billion U.S. dollars from its revenue.

The Biotechnology Market estimated size and share is projected to exceed USD 5.85 trillion by 2034, with a forecasted CAGR of 13.6% during the period.

This statistic shows the research and development intensity of biotechnology companies in selected countries for 2022 (or 2023, if available). As of that year, U.S. biotech R&D in the enterprise sector was around 0.4 percent of the GDP.

Survey of advanced technology, applications related to biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.

Biotechnology funding by the NIH was around 8.9 billion U.S. dollars during fiscal year 2023. This graph shows the total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2023 and estimates for FY 2024 and FY 2025.

In 2023, the production volume of the South Korean biotechnology industry fell to around 20.8 trillion South Korean won. Since 2004, the production volume has increased by about 760 percent.

Biotechnology use and development survey, indicators for innovative biotechnology firms for Canada and by region , biennial survey from 1999 to 2005.

Statistics on Biotechnology Use: Research personnel in internal R&D activities in Biotechnology by year and sector/unit. National.

Statistics on Biotechnology Use: Biotechnology indicators by branch of activity. National.

This statistic depicts a selection of global top biotechnology companies based on market capitalization as of October 4, 2023. At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked first among such companies, with a market capitalization of over 300 billion U.S. dollars.

Global biotechnology

AbbVie and Novo Nordisk are among the largest mostly biotech-oriented companies in the world. In October 2023, AbbVie, a company based in the U.S., had a market capitalization of 260 billion U.S. dollars, while Novo Nordisk had a market capitalization of some 300 billion U.S. dollars. As of 2020, there were 1,500 companies in the United States dedicated to biotechnology, while, in comparison, Germany had 753 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States.

In the United States, medical biotechnology is a significant component of the whole biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated over 21 billion U.S. dollars in revenue globally in 2022. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 88.6 million acres of corn crops in the United States, only 6.2 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.

Biotechnology use and development survey, indicators for innovative biotechnology firms by firms size for Canada, biennial survey from 1999 to 2005.

Statistics on Biotechnology Use: Researchers in internal R&D activities in Biotechnology by year and sectors/unit. National.

Access the summary of the Separation Systems For Commercial Biotechnology market report, featuring key insights, executive summary, market size, CAGR, growth rate, and future outlook.

Statistics on Biotechnology Use: Expenditure on internal R&D in Biotechnology by years and origin of funds/unit. National.

Statistics on Biotechnology Use: Total Sectors. Expenditure and personnel in internal R&D in Biotechnology by Autonomous Community. Autonomous Communities and Cities.

As of 2021, the United States' share of the total global biotech value stood at nearly 59 percent, while China had around 11 percent. This statistic illustrates the share of the total biotech company value worldwide as of 2021, by country.

Statistics on Biotechnology Use: Total internal expenditure in R&D activities in Biotechnology by years and origin of funds/unit. National.

N. phenotypes = number of sows with phenotyp ic data; N. genotypes = number of sows with genotyp ic and phenotyp ic data; Mean parity n = mean parity number corresponding to the phenotypes in the data; Mean = mean of the phenotype data, averaged over all parities;  = (uncorrected) standard deviation of the phenotype data. The traits included in the analyses were: LB = number of piglets born alive in a litter, LW = weight of the liveborn piglets in a litter in kg; TB = number of piglets born in a litter; TW = weight of the piglets born in a litter in kg.

Statistics for 3 raw databases.

The characteristics of the included studies.